^ Back to Top

BPJ 77 September 2016

Best Practice Journal

Treatment of hepatitis C (HCV) has changed

Three new oral medicine regimens for the treatment of hepatitis C, known as directly acting antivirals (DAAs), are fully subsidised from 1 July, 2016. View Article